Vyome Holdings, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 1.75 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 12.28M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company’s lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinical stage for the treatment of bacterial conjunctivitis. It also develops VT-1908, a topical eye drop is an inosine 5′-monophosphate dehydrogenase enzyme inhibitor to treat immunoinflammatory conditions of the eye; and VB-1953, which is in phase 2 clinical stage for the treatment of inflammatory acne. In addition, the company develops antifungal products using the molecular replacement therapy (MRT) platform. It has a collaboration and license agreement with Sun Pharma Laboratories Limited to develop and commercialize next-generation antifungal products. The company is based in Cambridge, Massachusetts.
Details
| Name | Vyome Holdings, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 14 |
| Founded | 2017 |
| Ceo | Venkateswarlu Nelabhotla |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US92943X1046 |
| Cusip | 92943X104 |
| Cik | 0001427570 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Venkateswarlu Nelabhotla M.B.A. | Co-Founder, Chief Executive Officer, President and Director |
| Dr. Shiladitya Sengupta M.Sc., Ph.D. | Co-Founder, Director and Member of Scientific and Clinical Advisory Board |
| Jerry Leonard C.P.A., M.B.A. | Chief Financial Officer, Principal Financial and Accounting Officer |
| Dr. Richard Fahrner Ph.D. | Chief Technology Officer |
| Jules Abraham | Investor Relations Officer |
| Dr. Charles G. Chavdarian Ph.D. | Senior Vice President of Product Development and Regulatory CMC |
| Dr. Tamara Agajanov M.D. | Senior Vice President of Clinical Development |
Contact
| Address | Harvard Square, One Mifflin Place, Cambridge, Massachusetts 02138, United States |
| Phone | 973 832 8147 |
| Website | https://www.vyometx.com |